Literature DB >> 33962353

Low MoCA performances correlate with suicidal ideation in late-life depression.

Stéphane Richard-Devantoy1, Icoquih Badillo-Amberg2, Kyle T Greenway2, Maria Di Tomasso3, Gustavo Turecki2, J A Bertrand4.   

Abstract

Late-life depression remains an underdiagnosed clinical entity, mainly because the presence of cognitive impairment in the elderly leads clinicians to suspect dementia rather than depression. Our objective was to analyze the cognitive abilities of elderly depressed patients using the Montreal Cognitive Assessment (MoCA) in relation to the presence or absence of suicidal ideation. The MoCA, Beck Scale of Suicidal Ideation, Hamilton Anxiety Scale, and Hamilton Depression Scale were administered to 72 patients with a recent history of late life depression: 43 with suicidal ideation and 29 non-suicidal controls. The results show that suicidal patients demonstrated significantly worse performance on the MoCA total score and the delayed recall subtest in comparison to non-suicidal controls. In addition, after adjusting for age and depression, poorer performance on the MoCA total score correlated to the presence of suicidal ideation. We found that the MoCA total score is able to predict the presence of suicidal ideation in depressed elderly patients in a fair-to-good manner. As late-life depression is already established as a potential prodrome of dementia, longitudinal follow-up may determine whether depressed individuals with suicidal ideation are at higher risk of converting to dementia.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cognition; Depression; Elderly; MoCA; Screening; Suicidal ideation

Year:  2021        PMID: 33962353     DOI: 10.1016/j.psychres.2021.113957

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  1 in total

1.  Evaluation of cognitive, mental, and sleep patterns of post-acute COVID-19 patients and their correlation with thorax CT.

Authors:  Ömer Faruk Bolattürk; Akın Cem Soylu
Journal:  Acta Neurol Belg       Date:  2022-06-26       Impact factor: 2.471

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.